国新健康
(000503)
| 流通市值：99.04亿 | | | 总市值：101.76亿 |
| 流通股本：9.55亿 | | | 总股本：9.81亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 50,467,725.8 | 356,896,420.31 | 200,175,797.05 | 137,393,382.51 |
| 营业收入 | 50,467,725.8 | 356,896,420.31 | 200,175,797.05 | 137,393,382.51 |
| 二、营业总成本 | 101,542,262.28 | 497,601,832.31 | 310,493,245.6 | 214,938,640.59 |
| 营业成本 | 57,930,039.64 | 302,447,456.39 | 193,333,505.34 | 141,271,985.72 |
| 税金及附加 | 58,673.38 | 2,479,857.35 | 1,270,673.72 | 716,279.28 |
| 销售费用 | 14,923,130.53 | 72,270,820.15 | 42,708,861.39 | 25,731,510.07 |
| 管理费用 | 26,425,606.59 | 118,099,931.98 | 71,392,383.75 | 46,665,327.62 |
| 研发费用 | 542,165.06 | 339,291.6 | - | 0 |
| 财务费用 | 1,662,647.08 | 1,964,474.84 | 1,787,821.4 | 553,537.9 |
| 其中:利息费用 | 2,187,521.63 | 8,310,544 | 5,715,954.47 | 3,836,425.01 |
| 其中:利息收入 | 605,842.61 | 6,520,652.18 | 4,092,215.61 | 3,353,270.01 |
| 加:公允价值变动收益 | - | 6,340,000 | - | - |
| 加:投资收益 | 4,320,158.46 | 143,019,379.11 | 72,827,431.33 | 1,218,785.01 |
| 净敞口套期收益 | - | 0 | - | - |
| 资产处置收益 | 0 | 33,591.2 | 55,933.8 | 30,154.44 |
| 资产减值损失(新) | -1,940,358.04 | -1,961,491.58 | 2,852,277.95 | 2,905,608.65 |
| 信用减值损失(新) | 3,398,061.31 | -23,186,486.13 | -3,190,634.52 | -5,264,558.59 |
| 其他收益 | 376,689.71 | 690,739.95 | 521,231.53 | 481,881.25 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -44,919,985.04 | -15,769,679.45 | -37,251,208.46 | -78,173,387.32 |
| 加:营业外收入 | 6,257.87 | 5,664,099.58 | 5,531,933.08 | 5,511,925.55 |
| 减:营业外支出 | 38,008.68 | 1,586,974.34 | 344,913.17 | 344,912.96 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -44,951,735.85 | -11,692,554.21 | -32,064,188.55 | -73,006,374.73 |
| 减:所得税费用 | 624,803.12 | -226,004.45 | -26,402.34 | -26,402.34 |
| 六、净利润 | -45,576,538.97 | -11,466,549.76 | -32,037,786.21 | -72,979,972.39 |
| 持续经营净利润 | -45,576,538.97 | -11,466,549.76 | -32,037,786.21 | -72,979,972.39 |
| 归属于母公司股东的净利润 | -45,576,538.97 | -10,375,438.31 | -30,946,674.76 | -72,981,492.63 |
| 少数股东损益 | - | -1,091,111.45 | -1,091,111.45 | 1,520.24 |
| (一)基本每股收益 | -0.05 | -0.01 | -0.03 | -0.07 |
| (二)稀释每股收益 | -0.05 | -0.01 | -0.03 | -0.07 |
| 八、其他综合收益 | -17,300.36 | -1,315,518.23 | -145,922.56 | 86,978.58 |
| 归属于母公司股东的其他综合收益 | -17,300.36 | -1,315,518.23 | -145,922.56 | 86,978.58 |
| 九、综合收益总额 | -45,593,839.33 | -12,782,067.99 | -32,183,708.77 | -72,892,993.81 |
| 归属于母公司股东的综合收益总额 | -45,593,839.33 | -11,690,956.54 | -31,092,597.32 | -72,894,514.05 |
| 归属于少数股东的综合收益总额 | - | -1,091,111.45 | -1,091,111.45 | 1,520.24 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-26 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |